News

The Latest News from LGM Pharma

LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable...
LGM Pharma Expands Client Service Offerings Supporting The Provision of High Quality Active Pharmaceutical Ingredients (APIs) For 503B Outsourcing Facilities
Erlanger, Kentucky, June 24, 2019 – LGM Pharma, LLC, a leader in Active Pharmaceutical Ingredient (API)...
ORPHANION Partners with API Sourcing Leader LGM Pharma to Expand Global Access to Its Niche API Services
March 18, 2019, Basel, Switzerland and Erlanger, Kentucky, USA – Orphanion AG, a CRO/CMO that focuses...
LGM Pharma Announces New CEO
ERLANGER, Kentucky / Boca Raton, Florida—LGM Pharma, an innovation-driven active pharmaceutical ingredient...
LGM Pharma Acquires Compounding Business Division From Zeta
Erlanger, KY / Boca Raton, FL - LGM Pharma LLC today completed the acquisition of Zeta Pharmaceuticals’...
New Harbor Capital Acquires Majority Interest in LGM Pharma
Chicago-based private equity firm New Harbor Capital completed a majority equity investment in LGM Pharma,...